胰腺隔离性瘤的加快与逐步内镜治疗:一个随机对照试验 (ACCELERATE)
Olsen Ga1, Schmidt Pn1, Hadi A1
1Pancreatitis Centre East, Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
概括
加快治疗方案显著减少了大壁死病 (WON) 的并发症和住院时间. 这种方法为严重的胰腺疾病提供了一个有前途的替代方案.
科学领域:
- 胃肠病学
- 干预性内镜
- 手术治疗
背景情况:
- 内镜升级治疗是胰腺隔离性瘤 (WON) 的标准.
- 大量WON病例导致大量住院.
- 一个加快的方案被假设减少停留时间 (LOS) 和并发症.
研究的目的:
- 评估大型WON的加速治疗方案.
- 为了比较加快的协议与标准的步骤.
- 评估对LOS,主要并发症和死亡率的影响.
主要方法:
- 一个单中心,开放标签,随机对照试验进行.
- 患有WON> 15厘米的患者被随机分配到加速或升级治疗.
- 主要终点包括死亡,严重并发症和LOS>58天.
主要成果:
- 该试验包括25名患者;由于安全问题,该试验在升级组中提前结束.
- 加速治疗组的初级复合结果率明显较低 (8. 3% 与 61. 5% 相比).
- 在加速治疗组中,严重并发症 (0. 0% vs 46. 2%) 和LOS (32. 5 vs 68. 5天) 显著减少.
结论:
- 一个加速治疗方案似乎优于大WON的逐步方法.
- 这种方案可以减少主要并发症,炎症负担和LOS.
- 建议采用加速方案来治疗大WON.
相关概念视频
Endoscopic Procedures V: ERCP
898
Endoscopic Retrograde Cholangiopancreatography (ERCP) is a diagnostic procedure that combines endoscopy and fluoroscopy to diagnose and treat conditions related to the bile ducts, pancreatic ducts, and gallbladder. This procedure is beneficial for identifying and addressing blockages, gallstones, strictures, and tumors within the biliary or pancreatic systems. ERCP is both diagnostic and therapeutic, offering the ability to visualize and treat identified problems in one session.
Patient...
Patient...
898
Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128


